Nivolumab therapy before vemurafenib administration induces a severe skin rash

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e169-e171. doi: 10.1111/jdv.13892. Epub 2016 Aug 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Immunological / adverse effects
  • Exanthema / chemically induced*
  • Exanthema / diagnosis
  • Female
  • Humans
  • Male
  • Melanoma / drug therapy
  • Middle Aged
  • Nivolumab / adverse effects*
  • Nivolumab / therapeutic use
  • Severity of Illness Index
  • Skin Neoplasms / drug therapy
  • Vemurafenib / therapeutic use*

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Vemurafenib
  • Nivolumab